| Literature DB >> 23508913 |
K H Chan1, M K Yan, K K W To, S K Lau, P C Woo, V C C Cheng, W S Li, J F W Chan, H Tse, K Y Yuen.
Abstract
The human colorectal adenocarcinoma-derived Caco-2 cell line was evaluated as a means isolating common respiratory viruses from nasopharyngeal aspirates for the diagnosis of respiratory diseases. One hundred eighty-nine direct immunofluorescence positive nasopharyngeal aspirates obtained from patients with various viral respiratory diseases were cultured in the presence of Caco-2 cells or the following conventional cell lines: LLC-MK2, MDCK, HEp-2, and A549. Caco-2 cell cultures effectively propagated the majority (84%) of the viruses present in nasopharyngeal aspirate samples compared with any positive cultures obtained using the panel cells (78%) or individual cell line MDCK (38%), HEp-2 (21%), LLC-MK2 (27%), or A549 (37%) cell lines. The differences against individual cell line were statistically significant (P = < 0.000001). Culture in Caco-2 cells resulted in the isolation of 85% (36/42) of viruses which were not cultivated in conventional cell lines. By contrast, 80% (24/30) of viruses not cultivated in Caco-2 cells were isolated using the conventional panel. The findings indicated that Caco-2 cells were sensitive to a wide range of viruses and can be used to culture a broad range of respiratory viruses.Entities:
Mesh:
Year: 2013 PMID: 23508913 PMCID: PMC7167083 DOI: 10.1002/jmv.23538
Source DB: PubMed Journal: J Med Virol ISSN: 0146-6615 Impact factor: 2.327
Comparison of the Caco‐2 Cell Line With Conventional Cell Lines Used in the Recovery of Respiratory Viruses From Nasopharyngeal Aspirate
| Direct immunofluorescence antigen test positive | Number of nasopharyngeal aspirates | Caco‐2 number positive (%) | A549 number positive (%) | HEp‐2 number positive (%) | LLC‐MK2 number positive (%) | MDCK number positive (%) |
|---|---|---|---|---|---|---|
| RSV | 27 | 20 (74%) | 14 (52%) | 22 (81%) | 5 (19%) | 0% |
| Flu A | 38 | 35 (92%) | 4 (11%) | 0% | 3 (8%) | 36 (95%) |
| Flu B | 32 | 25 (78%) | 7 (22%) | 0% | 3 (9%) | 31 (97%) |
| PIV‐1 | 20 | 16 (80%) | 20 (100%) | 0% | 20 (100%) | 3 (15%) |
| PIV‐2 | 11 | 11 (100%) | 5 (45%) | 1 (9%) | 7 (64%) | 1(9%) |
| PIV‐3 | 30 | 22 (73%) | 6 (20%) | 4 (13%) | 11 (37%) | 0% |
| PIV‐4 | 18 | 18 (100%) | 1 (6%) | 1 (6%) | 2 (11%) | 1 (6%) |
| AdV | 13 | 12 (92%) | 13 (100%) | 12 (92%) | 0% | 0% |
| Total | 189 | 159 (84%) | 70 (37%) | 40 (21%) | 51 (27%) | 72 (38%) |
RSV, respiratory syncytial virus; Flu A, influenza A; Flu B, influenza B; PIV, parainfluenza virus; AdV, adenovirus.
Figure 1CPE in Caco‐2 cells following infections with (A) RSV, (B) AdV, (C) Flu A, (D) Flu B, and (E) a virus negative nasopharyngeal aspirate.
Figure 2Antigen expression in Caco2 cells identified by direct immunofluorescence staining using a panel of monoclonal antibodies specific for respiratory viruses. A: RSV, (B) AdV, (C) Flu A, (D) Flu B, (E) PIV‐1, (F) PIV‐2, (G) PIV‐3, (H) PIV‐4, and (I) a virus negative nasopharyngeal aspirate.
Different Caco‐2 Combinations With Panel Cell Lines Used in the Recovery of Respiratory Viruses
| Cell lines | RSV (n = 27) | Flu A (n = 38) | Flu B (n = 32) | PIV‐1 (n = 20) | PIV‐2 (n = 11) | PIV‐3 (n = 30) | PIV‐4 (n = 15) | AdV (n = 13) | Total culture positive | Percentage positive (%) |
|---|---|---|---|---|---|---|---|---|---|---|
| Caco‐2 | 20 | 35 | 25 | 16 | 11 | 22 | 18 | 12 | 159 | 84 |
| Caco‐2 + A549 | 22 | 35 | 25 | 20 | 11 | 23 | 18 | 13 | 167 | 88 |
| Caco‐2 + MDCK | 20 | 38 | 32 | 16 | 11 | 22 | 18 | 12 | 169 | 89 |
| Caco‐2 + HEp‐2 | 25 | 35 | 25 | 16 | 11 | 22 | 18 | 13 | 165 | 87 |
| Caco‐2 + LLC‐MK2 | 23 | 35 | 25 | 20 | 11 | 23 | 18 | 12 | 167 | 88 |
RSV, respiratory syncytial virus; Flu A, influenza A; Flu B, influenza B; PIV, parainfluenza virus; AdV, adenovirus.
Evaluation of Negative Cultures Following Culture With Panel Cells Compared to Culture With Caco‐2 Cells Resulting in Positive Viral Propagation and Vice Versa
| Virus type | Panel cells negative | Caco‐2 cells positive | Caco‐2 cells negative | Panel cells positive |
|---|---|---|---|---|
| RSV | 2 | 2 | 7 | 7 |
| Flu A | 2 | 2 | 3 | 3 |
| Flu B | 1 | 1 | 7 | 7 |
| PIV‐1 | 0 | 0 | 4 | 4 |
| PIV‐2 | 4 | 4 | 0 | 0 |
| PIV‐3 | 17 | 11 | 8 | 2 |
| PIV‐4 | 16 | 16 | 0 | 0 |
| AdV | 0 | 0 | 1 | 1 |
| Total | 42 | 36 | 30 | 24 |
RSV, respiratory syncytial virus; Flu A, influenza A; Flu B, influenza B; PIV, parainfluenza virus; AdV, adenovirus.